134 related articles for article (PubMed ID: 18328842)
1. Emergency medical service predictive instrument-aided diagnosis and treatment of acute coronary syndromes and ST-segment elevation myocardial infarction in the IMMEDIATE trial.
Selker HP; Beshansky JR; Ruthazer R; Sheehan PR; Sayah AJ; Atkins JM; Aufderheide TP; Pirrallo RG; D'Agostino RB; Massaro JM; Griffith JL
Prehosp Emerg Care; 2011; 15(2):139-48. PubMed ID: 21366431
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes after acute myocardial infarction in countries with different socioeconomic environments: an international prospective cohort study.
Kämpfer J; Yagensky A; Zdrojewski T; Windecker S; Meier B; Pavelko M; Sichkaruk I; Kasprzyk P; Gruchala M; Giacomini M; Räber L; Saner H
BMJ Open; 2017 Aug; 7(8):e012715. PubMed ID: 28801383
[TBL] [Abstract][Full Text] [Related]
3. Cerebral embolism following thrombolytic therapy for acute myocardial infarction: the second reported case.
Bostan M; Kanat A; Sen M; Kazdal H; Bostan H
Cardiovasc J Afr; 2010; 21(3):155-7. PubMed ID: 20532455
[TBL] [Abstract][Full Text] [Related]
4. Thrombolytic use in the region around Amarillo, Texas, in patients with ST elevation myocardial infarction.
McMaster KS; Chatterjee T; McBrayer D; Brabham D
Proc (Bayl Univ Med Cent); 2018 Jan; 31(1):9-11. PubMed ID: 29686544
[TBL] [Abstract][Full Text] [Related]
5. Can risk modelling improve treatment decisions in asymptomatic carotid stenosis?
Burke JF; Morgenstern LB; Hayward RA
BMC Neurol; 2019 Nov; 19(1):295. PubMed ID: 31757218
[TBL] [Abstract][Full Text] [Related]
6. The use of patient-specific equipoise to support shared decision-making for clinical care and enrollment into clinical trials.
Selker HP; Daudelin DH; Ruthazer R; Kwong M; Lorenzana RC; Hannon DJ; Wong JB; Kent DM; Terrin N; Moreno-Koehler AD; McAlindon TE
J Clin Transl Sci; 2019 Feb; 3(1):27-36. PubMed ID: 31404154
[TBL] [Abstract][Full Text] [Related]
7. Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trials.
Kent DM; Nelson J; Dahabreh IJ; Rothwell PM; Altman DG; Hayward RA
Int J Epidemiol; 2016 Dec; 45(6):2075-2088. PubMed ID: 27375287
[TBL] [Abstract][Full Text] [Related]
8. Using internally developed risk models to assess heterogeneity in treatment effects in clinical trials.
Burke JF; Hayward RA; Nelson JP; Kent DM
Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):163-9. PubMed ID: 24425710
[TBL] [Abstract][Full Text] [Related]
9. Random treatment assignment using mathematical equipoise for comparative effectiveness trials.
Selker HP; Ruthazer R; Terrin N; Griffith JL; Concannon T; Kent DM
Clin Transl Sci; 2011 Feb; 4(1):10-6. PubMed ID: 21348950
[TBL] [Abstract][Full Text] [Related]
10. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal.
Kent DM; Rothwell PM; Ioannidis JP; Altman DG; Hayward RA
Trials; 2010 Aug; 11():85. PubMed ID: 20704705
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of ST-segment-elevation myocardial infarction regionalization strategies.
Concannon TW; Kent DM; Normand SL; Newhouse JP; Griffith JL; Cohen J; Beshansky JR; Wong JB; Aversano T; Selker HP
Circ Cardiovasc Qual Outcomes; 2010 Sep; 3(5):506-13. PubMed ID: 20664025
[TBL] [Abstract][Full Text] [Related]
12. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
Gibson CM; Murphy SA; Pride YB; Kirtane AJ; Aroesty JM; Stein EB; Ciaglo LN; Southard MC; Sabatine MS; Cannon CP; Braunwald E;
Am Heart J; 2008 Jan; 155(1):133-9. PubMed ID: 18082504
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
Gibson CM; Murphy SA; Montalescot G; Morrow DA; Ardissino D; Cohen M; Gulba DC; Kracoff OH; Lewis BS; Roguin N; Antman EM; Braunwald E;
J Am Coll Cardiol; 2007 Jun; 49(23):2238-46. PubMed ID: 17560287
[TBL] [Abstract][Full Text] [Related]
14. Early management of ST-segment elevation myocardial infarction.
Sura AC; Kelemen MD
Cardiol Clin; 2006 Feb; 24(1):37-51. PubMed ID: 16326255
[TBL] [Abstract][Full Text] [Related]
15. Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials.
De Luca G; Biondi-Zoccai G; Marino P
Ann Emerg Med; 2008 Dec; 52(6):665-76. PubMed ID: 19027496
[TBL] [Abstract][Full Text] [Related]
16. A percutaneous coronary intervention-thrombolytic predictive instrument to assist choosing between immediate thrombolytic therapy versus delayed primary percutaneous coronary intervention for acute myocardial infarction.
Kent DM; Ruthazer R; Griffith JL; Beshansky JR; Concannon TW; Aversano T; Grines CL; Zalenski RJ; Selker HP
Am J Cardiol; 2008 Mar; 101(6):790-5. PubMed ID: 18328842
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acute ST-segment elevation myocardial infarction in West Pomerania province of Poland. Comparison between primary coronary intervention and thrombolytic therapy.
Dryja T; Kornacewicz-Jach Z; Goracy J; Przybycień K; Jodko L; Skowronek A; Kurowski M; Zinka E
Kardiol Pol; 2006 Jun; 64(6):591-9; discussion 600-1. PubMed ID: 16810577
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
